

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.90822594 |
| 2 | maintenance of protein location in nucleus (GO:0051457) | 6.36551699 |
| 3 | somite rostral/caudal axis specification (GO:0032525) | 6.06735149 |
| 4 | cytidine metabolic process (GO:0046087) | 5.89049151 |
| 5 | cytidine catabolic process (GO:0006216) | 5.89049151 |
| 6 | cytidine deamination (GO:0009972) | 5.89049151 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.85164702 |
| 8 | protein localization to kinetochore (GO:0034501) | 5.49504005 |
| 9 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.44978812 |
| 10 | negative regulation of telomerase activity (GO:0051974) | 5.15396907 |
| 11 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.04916190 |
| 12 | negative regulation of epidermis development (GO:0045683) | 5.01123395 |
| 13 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.95577613 |
| 14 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.93972145 |
| 15 | interferon-gamma production (GO:0032609) | 4.93201961 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.80765240 |
| 17 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.61485143 |
| 18 | rRNA transcription (GO:0009303) | 4.57803686 |
| 19 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.57306581 |
| 20 | histone H4-K5 acetylation (GO:0043981) | 4.55365256 |
| 21 | histone H4-K8 acetylation (GO:0043982) | 4.55365256 |
| 22 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.54092274 |
| 23 | muscle organ morphogenesis (GO:0048644) | 4.50299581 |
| 24 | regulation of response to osmotic stress (GO:0047484) | 4.40128134 |
| 25 | cullin deneddylation (GO:0010388) | 4.31458895 |
| 26 | GDP-mannose metabolic process (GO:0019673) | 4.28864536 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.26016477 |
| 28 | regulation of cilium movement (GO:0003352) | 4.21220013 |
| 29 | primitive streak formation (GO:0090009) | 4.14947631 |
| 30 | maintenance of protein localization in organelle (GO:0072595) | 4.14483572 |
| 31 | histone H4-K12 acetylation (GO:0043983) | 4.13963399 |
| 32 | rRNA methylation (GO:0031167) | 4.10558937 |
| 33 | nucleoside transmembrane transport (GO:1901642) | 4.08655494 |
| 34 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.07366217 |
| 35 | mitotic sister chromatid segregation (GO:0000070) | 4.06878193 |
| 36 | hormone catabolic process (GO:0042447) | 4.00855499 |
| 37 | coenzyme catabolic process (GO:0009109) | 3.98561954 |
| 38 | protein deneddylation (GO:0000338) | 3.97028189 |
| 39 | notochord development (GO:0030903) | 3.95451977 |
| 40 | negative regulation of telomere maintenance (GO:0032205) | 3.89368569 |
| 41 | protein localization to chromosome, centromeric region (GO:0071459) | 3.88105084 |
| 42 | formation of translation preinitiation complex (GO:0001731) | 3.87314125 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.85468246 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.85468246 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.85468246 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.85468246 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.85468246 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.85468246 |
| 49 | regulation of translation in response to stress (GO:0043555) | 3.79508810 |
| 50 | rRNA modification (GO:0000154) | 3.75375615 |
| 51 | cellular extravasation (GO:0045123) | 3.74504538 |
| 52 | quinone metabolic process (GO:1901661) | 3.69986364 |
| 53 | phenol-containing compound catabolic process (GO:0019336) | 3.67922238 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 3.67556767 |
| 55 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.65486098 |
| 56 | DNA replication checkpoint (GO:0000076) | 3.63196587 |
| 57 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.62998824 |
| 58 | phagocytosis, recognition (GO:0006910) | 3.61047064 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54190909 |
| 60 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.54009609 |
| 61 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.53425238 |
| 62 | heterochromatin organization (GO:0070828) | 3.47579685 |
| 63 | response to peptidoglycan (GO:0032494) | 3.47096720 |
| 64 | response to dietary excess (GO:0002021) | 3.45965778 |
| 65 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.43564554 |
| 66 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.43564554 |
| 67 | thrombin receptor signaling pathway (GO:0070493) | 3.31816586 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.29573236 |
| 69 | negative regulation of cell killing (GO:0031342) | 3.29573236 |
| 70 | sister chromatid segregation (GO:0000819) | 3.28589677 |
| 71 | regulation of telomerase activity (GO:0051972) | 3.25795917 |
| 72 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.22668705 |
| 73 | amino sugar catabolic process (GO:0046348) | 3.19757015 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19708478 |
| 75 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16523258 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.11089749 |
| 77 | maternal placenta development (GO:0001893) | 3.10928216 |
| 78 | vitamin A metabolic process (GO:0006776) | 3.10432460 |
| 79 | glycosphingolipid catabolic process (GO:0046479) | 3.10226185 |
| 80 | nucleoside transport (GO:0015858) | 3.09086087 |
| 81 | neutrophil activation (GO:0042119) | 3.08735297 |
| 82 | granulocyte activation (GO:0036230) | 3.07458352 |
| 83 | DNA damage response, detection of DNA damage (GO:0042769) | 3.03082913 |
| 84 | regulation of gene silencing by RNA (GO:0060966) | 3.02118339 |
| 85 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.02118339 |
| 86 | regulation of gene silencing by miRNA (GO:0060964) | 3.02118339 |
| 87 | retinoic acid receptor signaling pathway (GO:0048384) | 3.01855609 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 3.01796887 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.01382895 |
| 90 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.01161184 |
| 91 | immunoglobulin mediated immune response (GO:0016064) | 3.01121500 |
| 92 | intestinal epithelial cell development (GO:0060576) | 3.00386476 |
| 93 | chromatin assembly (GO:0031497) | 2.99796413 |
| 94 | N-acetylneuraminate metabolic process (GO:0006054) | 2.99388088 |
| 95 | B cell mediated immunity (GO:0019724) | 2.99054350 |
| 96 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.98218653 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.97907730 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97000803 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 2.95457304 |
| 100 | pseudouridine synthesis (GO:0001522) | 2.94783300 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.91935420 |
| 102 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91323785 |
| 103 | nuclear pore complex assembly (GO:0051292) | 2.90899542 |
| 104 | positive regulation of protein deacetylation (GO:0090312) | 2.90649367 |
| 105 | endosome to melanosome transport (GO:0035646) | 2.90246795 |
| 106 | endosome to pigment granule transport (GO:0043485) | 2.90246795 |
| 107 | thyroid hormone generation (GO:0006590) | 2.88981313 |
| 108 | oligosaccharide catabolic process (GO:0009313) | 2.88808893 |
| 109 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.88358434 |
| 110 | positive regulation of macrophage cytokine production (GO:0060907) | 2.87819172 |
| 111 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.87663413 |
| 112 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.87279785 |
| 113 | glycolipid catabolic process (GO:0019377) | 2.85743390 |
| 114 | pinocytosis (GO:0006907) | 2.85629746 |
| 115 | negative regulation of phagocytosis (GO:0050765) | 2.84997100 |
| 116 | histone H4-K16 acetylation (GO:0043984) | 2.83545786 |
| 117 | detection of molecule of bacterial origin (GO:0032490) | 2.82818221 |
| 118 | regulation of microtubule-based movement (GO:0060632) | 2.80049252 |
| 119 | detection of other organism (GO:0098543) | 2.78718277 |
| 120 | T cell migration (GO:0072678) | 2.78589402 |
| 121 | epoxygenase P450 pathway (GO:0019373) | 2.78415621 |
| 122 | cell proliferation involved in metanephros development (GO:0072203) | 2.78194886 |
| 123 | melanosome organization (GO:0032438) | 2.76716391 |
| 124 | myeloid cell activation involved in immune response (GO:0002275) | 2.76475033 |
| 125 | barbed-end actin filament capping (GO:0051016) | 2.75750012 |
| 126 | positive regulation of tissue remodeling (GO:0034105) | 2.74846387 |
| 127 | macrophage activation involved in immune response (GO:0002281) | 2.73729841 |
| 128 | keratan sulfate catabolic process (GO:0042340) | 2.70518491 |
| 129 | bone trabecula formation (GO:0060346) | 2.70234760 |
| 130 | negative regulation of bone resorption (GO:0045779) | 2.70020692 |
| 131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69458683 |
| 132 | L-ascorbic acid metabolic process (GO:0019852) | 2.69251608 |
| 133 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.68736113 |
| 134 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68468308 |
| 135 | response to host immune response (GO:0052572) | 2.68446884 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.68446884 |
| 137 | establishment of endothelial barrier (GO:0061028) | 2.68380831 |
| 138 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68053700 |
| 139 | nuclear pore organization (GO:0006999) | 2.66661040 |
| 140 | negative regulation of gene silencing (GO:0060969) | 2.66191206 |
| 141 | regulation of G0 to G1 transition (GO:0070316) | 2.65047187 |
| 142 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.65023269 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.65023269 |
| 144 | cellular response to arsenic-containing substance (GO:0071243) | 2.64844287 |
| 145 | primary alcohol catabolic process (GO:0034310) | 2.63547079 |
| 146 | leukocyte degranulation (GO:0043299) | 2.63256873 |
| 147 | regulation of telomere maintenance (GO:0032204) | 2.61209264 |
| 148 | apoptotic DNA fragmentation (GO:0006309) | 2.60755364 |
| 149 | ribosome biogenesis (GO:0042254) | 2.60701200 |
| 150 | type I interferon signaling pathway (GO:0060337) | 2.60479396 |
| 151 | cellular response to type I interferon (GO:0071357) | 2.60479396 |
| 152 | pore complex assembly (GO:0046931) | 2.59251884 |
| 153 | response to type I interferon (GO:0034340) | 2.58303338 |
| 154 | respiratory burst (GO:0045730) | 2.58270283 |
| 155 | ceramide catabolic process (GO:0046514) | 2.57363974 |
| 156 | detection of bacterium (GO:0016045) | 2.55679735 |
| 157 | regulation of mast cell activation (GO:0033003) | 2.55045696 |
| 158 | B cell homeostasis (GO:0001782) | 2.54041847 |
| 159 | regulation of interferon-alpha production (GO:0032647) | 2.51985556 |
| 160 | positive regulation of isotype switching (GO:0045830) | 2.51431305 |
| 161 | peptide catabolic process (GO:0043171) | 2.50496782 |
| 162 | detection of external biotic stimulus (GO:0098581) | 2.49476337 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49408502 |
| 164 | regulation of platelet aggregation (GO:0090330) | 2.49347149 |
| 165 | positive regulation of interferon-alpha production (GO:0032727) | 2.47926772 |
| 166 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.47617567 |
| 167 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.46357109 |
| 168 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.46118738 |
| 169 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45736736 |
| 170 | positive regulation of macrophage differentiation (GO:0045651) | 2.45429040 |
| 171 | dendritic cell migration (GO:0036336) | 2.44309990 |
| 172 | negative regulation of innate immune response (GO:0045824) | 2.43916066 |
| 173 | B cell receptor signaling pathway (GO:0050853) | 2.41277081 |
| 174 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.40417303 |
| 175 | regulation of platelet activation (GO:0010543) | 2.40333355 |
| 176 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.39017499 |
| 177 | positive regulation of DNA recombination (GO:0045911) | 2.38843784 |
| 178 | negative thymic T cell selection (GO:0045060) | 2.37581110 |
| 179 | regulation of B cell differentiation (GO:0045577) | 2.37089450 |
| 180 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.36807649 |
| 181 | response to host (GO:0075136) | 2.32339933 |
| 182 | response to host defenses (GO:0052200) | 2.32339933 |
| 183 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.32339933 |
| 184 | regulation of necroptotic process (GO:0060544) | 2.32126903 |
| 185 | phagocytosis, engulfment (GO:0006911) | 2.31502789 |
| 186 | lymphocyte homeostasis (GO:0002260) | 2.31024577 |
| 187 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.30672428 |
| 188 | positive regulation of mast cell activation (GO:0033005) | 2.30272799 |
| 189 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.29469548 |
| 190 | neutrophil mediated immunity (GO:0002446) | 2.27590482 |
| 191 | regulation of antigen processing and presentation (GO:0002577) | 2.26886040 |
| 192 | negative regulation of T cell mediated immunity (GO:0002710) | 2.26505574 |
| 193 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.26110697 |
| 194 | microglial cell activation (GO:0001774) | 2.25919617 |
| 195 | regulation of mast cell degranulation (GO:0043304) | 2.25475822 |
| 196 | positive regulation of interferon-beta production (GO:0032728) | 2.25010614 |
| 197 | daunorubicin metabolic process (GO:0044597) | 11.0172464 |
| 198 | polyketide metabolic process (GO:0030638) | 11.0172464 |
| 199 | doxorubicin metabolic process (GO:0044598) | 11.0172464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.60832217 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.18581035 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.18581035 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.18581035 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.85862132 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.73671182 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49315328 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27855315 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.10746657 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06551308 |
| 11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01964483 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.96573913 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93436094 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85721551 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80678900 |
| 16 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.78910461 |
| 17 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.54119642 |
| 18 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.53057930 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.48599974 |
| 20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.48384700 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36741474 |
| 22 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.32689440 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.27816623 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19830657 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19164124 |
| 26 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.09263502 |
| 27 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.08558963 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.99962989 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.94273487 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92221714 |
| 31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.88526906 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88289614 |
| 33 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.87183307 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83800540 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83241830 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80826319 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.79314678 |
| 38 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.77269948 |
| 39 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.76776982 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76655337 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.76412820 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.75908764 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74578901 |
| 44 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.66775166 |
| 45 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65182326 |
| 46 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.64605507 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64248641 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63277921 |
| 49 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59596915 |
| 50 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.58798986 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58022161 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55150261 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54519276 |
| 54 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.53954490 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52950322 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48102909 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.46048983 |
| 58 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.45372437 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45370301 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44706808 |
| 61 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.43368069 |
| 62 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.42759100 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42746533 |
| 64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.42187320 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41982810 |
| 66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40723964 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39325168 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.38572508 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37965966 |
| 70 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.36238372 |
| 71 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35799322 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35404196 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35305171 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.34513388 |
| 75 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32632498 |
| 76 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32525171 |
| 77 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.31641754 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31027674 |
| 79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.30872708 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30834392 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30473175 |
| 82 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29936617 |
| 83 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28670808 |
| 84 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.28454970 |
| 85 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.28370407 |
| 86 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.27971700 |
| 87 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27620352 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25772946 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25318673 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24472234 |
| 91 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22946771 |
| 92 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.20875953 |
| 93 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20438017 |
| 94 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20142980 |
| 95 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.19817272 |
| 96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18809951 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18475400 |
| 98 | MAF_26560356_Chip-Seq_TH1_Human | 1.17977455 |
| 99 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17495574 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16981225 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16373488 |
| 102 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16164365 |
| 103 | * MYC_22102868_ChIP-Seq_BL_Human | 1.15118712 |
| 104 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14854887 |
| 105 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.14791546 |
| 106 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14588130 |
| 107 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.14548368 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14094238 |
| 109 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.13617261 |
| 110 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.13266961 |
| 111 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.12967402 |
| 112 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12789542 |
| 113 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.11070011 |
| 114 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10804759 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09791054 |
| 116 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09485574 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06464557 |
| 118 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05988247 |
| 119 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05693858 |
| 120 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.05479105 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05326539 |
| 122 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05020206 |
| 123 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05009295 |
| 124 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04416096 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04342021 |
| 126 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03217791 |
| 127 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02661046 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01772627 |
| 129 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.01534972 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00826907 |
| 131 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.99565454 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99123883 |
| 133 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.97890167 |
| 134 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.97263054 |
| 135 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96984359 |
| 136 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96938919 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96776042 |
| 138 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.95620474 |
| 139 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.95497532 |
| 140 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95243361 |
| 141 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95097240 |
| 142 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94790204 |
| 143 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94307517 |
| 144 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94036810 |
| 145 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.93790662 |
| 146 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93709165 |
| 147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93203516 |
| 148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93203516 |
| 149 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92950306 |
| 150 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92448720 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92356290 |
| 152 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91755472 |
| 153 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.91700226 |
| 154 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90805569 |
| 155 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89985206 |
| 156 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.88903410 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87878822 |
| 158 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87656978 |
| 159 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.86531334 |
| 160 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86295870 |
| 161 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84704015 |
| 162 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.84148107 |
| 163 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83927792 |
| 164 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83636466 |
| 165 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83422772 |
| 166 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83405995 |
| 167 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83403198 |
| 168 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.82856444 |
| 169 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82610451 |
| 170 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.81420407 |
| 171 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.80877076 |
| 172 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80775213 |
| 173 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.79523310 |
| 174 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.78353022 |
| 175 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.78097653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.48293148 |
| 2 | MP0003011_delayed_dark_adaptation | 4.11611897 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 3.99497141 |
| 4 | MP0006292_abnormal_olfactory_placode | 3.34842331 |
| 5 | MP0005394_taste/olfaction_phenotype | 3.22382677 |
| 6 | MP0005499_abnormal_olfactory_system | 3.22382677 |
| 7 | MP0005257_abnormal_intraocular_pressure | 3.03042336 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 2.99447190 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.97129501 |
| 10 | MP0003724_increased_susceptibility_to | 2.96052941 |
| 11 | MP0003303_peritoneal_inflammation | 2.89383719 |
| 12 | MP0003122_maternal_imprinting | 2.85749710 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.80248513 |
| 14 | MP0004858_abnormal_nervous_system | 2.75462782 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.64824759 |
| 16 | MP0003890_abnormal_embryonic-extraembry | 2.50671821 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.47193703 |
| 18 | MP0000678_abnormal_parathyroid_gland | 2.35103504 |
| 19 | MP0009840_abnormal_foam_cell | 2.32205402 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.29873539 |
| 21 | MP0000685_abnormal_immune_system | 2.28934634 |
| 22 | MP0002419_abnormal_innate_immunity | 2.20411983 |
| 23 | MP0006054_spinal_hemorrhage | 2.19476204 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.14823908 |
| 25 | MP0006082_CNS_inflammation | 2.13922130 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 2.07701159 |
| 27 | MP0002332_abnormal_exercise_endurance | 2.07692498 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 2.02648853 |
| 29 | MP0005451_abnormal_body_composition | 2.02355697 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.98373534 |
| 31 | MP0008057_abnormal_DNA_replication | 1.98257425 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.94682486 |
| 33 | MP0003121_genomic_imprinting | 1.93409065 |
| 34 | MP0002723_abnormal_immune_serum | 1.89109299 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.86538349 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.81680545 |
| 37 | MP0008789_abnormal_olfactory_epithelium | 1.80230425 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.76776877 |
| 39 | MP0009764_decreased_sensitivity_to | 1.75521826 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.73562221 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.70193166 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.70016811 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.69193215 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.66151045 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.46802207 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.45803610 |
| 47 | MP0000371_diluted_coat_color | 1.45296215 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.42692316 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.40960876 |
| 50 | MP0002398_abnormal_bone_marrow | 1.40952211 |
| 51 | MP0008260_abnormal_autophagy | 1.40853019 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.40403783 |
| 53 | MP0003646_muscle_fatigue | 1.40344765 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.38684374 |
| 55 | MP0003448_altered_tumor_morphology | 1.37855387 |
| 56 | MP0001293_anophthalmia | 1.35866051 |
| 57 | MP0001835_abnormal_antigen_presentation | 1.34798655 |
| 58 | MP0000716_abnormal_immune_system | 1.34381598 |
| 59 | MP0005380_embryogenesis_phenotype | 1.31634707 |
| 60 | MP0001672_abnormal_embryogenesis/_devel | 1.31634707 |
| 61 | MP0002127_abnormal_cardiovascular_syste | 1.31190825 |
| 62 | MP0000343_altered_response_to | 1.30909720 |
| 63 | MP0000858_altered_metastatic_potential | 1.30429773 |
| 64 | MP0003123_paternal_imprinting | 1.28048152 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 1.27801673 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.26906280 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.26906280 |
| 68 | MP0001849_ear_inflammation | 1.26220349 |
| 69 | MP0005023_abnormal_wound_healing | 1.25898058 |
| 70 | MP0003077_abnormal_cell_cycle | 1.25754842 |
| 71 | MP0003984_embryonic_growth_retardation | 1.25078400 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.24766409 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.21926833 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.20406315 |
| 75 | MP0009278_abnormal_bone_marrow | 1.18350799 |
| 76 | MP0002932_abnormal_joint_morphology | 1.17701469 |
| 77 | MP0008469_abnormal_protein_level | 1.14914289 |
| 78 | MP0002132_abnormal_respiratory_system | 1.14825088 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.11873967 |
| 80 | MP0000049_abnormal_middle_ear | 1.11087758 |
| 81 | MP0004510_myositis | 1.10329644 |
| 82 | MP0000490_abnormal_crypts_of | 1.09876185 |
| 83 | MP0004947_skin_inflammation | 1.09343742 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09307866 |
| 85 | MP0009785_altered_susceptibility_to | 1.08749031 |
| 86 | MP0003436_decreased_susceptibility_to | 1.08580068 |
| 87 | MP0003938_abnormal_ear_development | 1.08234254 |
| 88 | MP0000350_abnormal_cell_proliferation | 1.07755714 |
| 89 | MP0005083_abnormal_biliary_tract | 1.06956252 |
| 90 | MP0002092_abnormal_eye_morphology | 1.06584624 |
| 91 | MP0005174_abnormal_tail_pigmentation | 1.06181674 |
| 92 | MP0002102_abnormal_ear_morphology | 1.05280799 |
| 93 | MP0009763_increased_sensitivity_to | 1.04107171 |
| 94 | MP0001853_heart_inflammation | 1.02876685 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 1.01792105 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 1.00778531 |
| 97 | MP0005671_abnormal_response_to | 0.98850546 |
| 98 | MP0002405_respiratory_system_inflammati | 0.98741477 |
| 99 | MP0005266_abnormal_metabolism | 0.98452566 |
| 100 | MP0005508_abnormal_skeleton_morphology | 0.98100091 |
| 101 | MP0003091_abnormal_cell_migration | 0.97811704 |
| 102 | MP0005171_absent_coat_pigmentation | 0.97647489 |
| 103 | MP0003186_abnormal_redox_activity | 0.97232227 |
| 104 | MP0000604_amyloidosis | 0.97106969 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.96785237 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.94248400 |
| 107 | MP0005197_abnormal_uvea_morphology | 0.94126596 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.93088566 |
| 109 | MP0002086_abnormal_extraembryonic_tissu | 0.92219754 |
| 110 | MP0004133_heterotaxia | 0.91598115 |
| 111 | MP0002139_abnormal_hepatobiliary_system | 0.91381623 |
| 112 | MP0002970_abnormal_white_adipose | 0.91056235 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.89424475 |
| 114 | MP0000313_abnormal_cell_death | 0.89409624 |
| 115 | MP0008004_abnormal_stomach_pH | 0.88982239 |
| 116 | MP0008438_abnormal_cutaneous_collagen | 0.88455626 |
| 117 | MP0005164_abnormal_response_to | 0.86913144 |
| 118 | MP0000358_abnormal_cell_content/ | 0.86278049 |
| 119 | MP0005408_hypopigmentation | 0.86084067 |
| 120 | MP0002233_abnormal_nose_morphology | 0.83488689 |
| 121 | MP0003279_aneurysm | 0.83021359 |
| 122 | MP0001851_eye_inflammation | 0.82975950 |
| 123 | MP0005310_abnormal_salivary_gland | 0.82197678 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.81312787 |
| 125 | MP0002396_abnormal_hematopoietic_system | 0.80873235 |
| 126 | MP0003119_abnormal_digestive_system | 0.80671628 |
| 127 | MP0002085_abnormal_embryonic_tissue | 0.80117560 |
| 128 | MP0000249_abnormal_blood_vessel | 0.78737135 |
| 129 | MP0000428_abnormal_craniofacial_morphol | 0.76577908 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.76208593 |
| 131 | MP0003136_yellow_coat_color | 0.75855815 |
| 132 | MP0002751_abnormal_autonomic_nervous | 0.75572507 |
| 133 | MP0001800_abnormal_humoral_immune | 0.75158257 |
| 134 | MP0004272_abnormal_basement_membrane | 0.74580390 |
| 135 | MP0005365_abnormal_bile_salt | 0.74173467 |
| 136 | MP0005165_increased_susceptibility_to | 0.73911789 |
| 137 | MP0002722_abnormal_immune_system | 0.73713756 |
| 138 | MP0003195_calcinosis | 0.72906131 |
| 139 | MP0005025_abnormal_response_to | 0.72621655 |
| 140 | MP0000703_abnormal_thymus_morphology | 0.70610754 |
| 141 | MP0003315_abnormal_perineum_morphology | 0.70505041 |
| 142 | MP0009333_abnormal_splenocyte_physiolog | 0.70366454 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.69818435 |
| 144 | MP0001243_abnormal_dermal_layer | 0.68528390 |
| 145 | MP0002019_abnormal_tumor_incidence | 0.68457123 |
| 146 | MP0008932_abnormal_embryonic_tissue | 0.68210810 |
| 147 | MP0002166_altered_tumor_susceptibility | 0.67865350 |
| 148 | MP0002114_abnormal_axial_skeleton | 0.67515696 |
| 149 | MP0001790_abnormal_immune_system | 0.67293979 |
| 150 | MP0005387_immune_system_phenotype | 0.67293979 |
| 151 | MP0004883_abnormal_blood_vessel | 0.67287406 |
| 152 | MP0003828_pulmonary_edema | 0.67207726 |
| 153 | MP0005384_cellular_phenotype | 0.67198127 |
| 154 | MP0002420_abnormal_adaptive_immunity | 0.67155111 |
| 155 | MP0004233_abnormal_muscle_weight | 0.67122843 |
| 156 | MP0001819_abnormal_immune_cell | 0.66618012 |
| 157 | MP0002452_abnormal_antigen_presenting | 0.66600460 |
| 158 | MP0002429_abnormal_blood_cell | 0.66201193 |
| 159 | MP0002925_abnormal_cardiovascular_devel | 0.65670609 |
| 160 | MP0001270_distended_abdomen | 0.65530750 |
| 161 | MP0004808_abnormal_hematopoietic_stem | 0.65038752 |
| 162 | MP0004484_altered_response_of | 0.63827480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.04996500 |
| 2 | Hepatoblastoma (HP:0002884) | 5.61239589 |
| 3 | Multiple enchondromatosis (HP:0005701) | 5.33285013 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.71620032 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 4.68342457 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.17714772 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.15920937 |
| 8 | Ependymoma (HP:0002888) | 4.06182567 |
| 9 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.99217049 |
| 10 | Hypoplasia of the fovea (HP:0007750) | 3.99217049 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.96711151 |
| 12 | Rib fusion (HP:0000902) | 3.96229881 |
| 13 | Reduced antithrombin III activity (HP:0001976) | 3.91610025 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.88433366 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.74707215 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.73943502 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.72325103 |
| 18 | Petechiae (HP:0000967) | 3.64528657 |
| 19 | Abnormality of the lower motor neuron (HP:0002366) | 3.53885242 |
| 20 | Loss of speech (HP:0002371) | 3.51593783 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.36276275 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.36276275 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.36276275 |
| 24 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.35545846 |
| 25 | T lymphocytopenia (HP:0005403) | 3.35035309 |
| 26 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.34978494 |
| 27 | Abnormality of T cell number (HP:0011839) | 3.34390435 |
| 28 | Combined immunodeficiency (HP:0005387) | 3.34086566 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.33925220 |
| 30 | Hematochezia (HP:0002573) | 3.27050224 |
| 31 | Rhabdomyosarcoma (HP:0002859) | 3.24966044 |
| 32 | Prolonged bleeding time (HP:0003010) | 3.24790215 |
| 33 | Neoplasm of striated muscle (HP:0009728) | 3.23985582 |
| 34 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.19991815 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 3.18977952 |
| 36 | Embryonal renal neoplasm (HP:0011794) | 3.15070484 |
| 37 | Albinism (HP:0001022) | 3.13891442 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11156414 |
| 39 | Fused cervical vertebrae (HP:0002949) | 3.06465834 |
| 40 | Dysostosis multiplex (HP:0000943) | 3.02443829 |
| 41 | Trismus (HP:0000211) | 3.02273470 |
| 42 | Conjunctival telangiectasia (HP:0000524) | 3.01876206 |
| 43 | Ragged-red muscle fibers (HP:0003200) | 2.97242351 |
| 44 | Tongue fasciculations (HP:0001308) | 2.94494501 |
| 45 | Abnormality of the fovea (HP:0000493) | 2.93203675 |
| 46 | Rectal fistula (HP:0100590) | 2.92254689 |
| 47 | Rectovaginal fistula (HP:0000143) | 2.92254689 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.91834555 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 2.89564839 |
| 50 | Abnormality of the salivary glands (HP:0010286) | 2.88152588 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.84614273 |
| 52 | Abnormal lung lobation (HP:0002101) | 2.84281740 |
| 53 | Abnormal cartilage morphology (HP:0002763) | 2.83731073 |
| 54 | Recurrent viral infections (HP:0004429) | 2.80962424 |
| 55 | Abnormal platelet volume (HP:0011876) | 2.78928044 |
| 56 | Anomalous pulmonary venous return (HP:0010772) | 2.77530387 |
| 57 | Bifid tongue (HP:0010297) | 2.77516979 |
| 58 | Epistaxis (HP:0000421) | 2.70852272 |
| 59 | Partial duplication of thumb phalanx (HP:0009944) | 2.69652130 |
| 60 | Muscle fibrillation (HP:0010546) | 2.68111823 |
| 61 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.67665827 |
| 62 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.66993286 |
| 63 | Degeneration of anterior horn cells (HP:0002398) | 2.66968791 |
| 64 | Abnormality of the anterior horn cell (HP:0006802) | 2.66968791 |
| 65 | Astrocytoma (HP:0009592) | 2.66393669 |
| 66 | Abnormality of the astrocytes (HP:0100707) | 2.66393669 |
| 67 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.66334431 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.64412922 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.64412922 |
| 70 | Increased IgM level (HP:0003496) | 2.63381293 |
| 71 | Vaginal fistula (HP:0004320) | 2.63109443 |
| 72 | Increased mean platelet volume (HP:0011877) | 2.62047286 |
| 73 | Short humerus (HP:0005792) | 2.61047208 |
| 74 | Chromsome breakage (HP:0040012) | 2.57993931 |
| 75 | Abnormality of T cells (HP:0002843) | 2.56469892 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.54909364 |
| 77 | Optic neuritis (HP:0100653) | 2.54909364 |
| 78 | Encephalitis (HP:0002383) | 2.53901638 |
| 79 | Intestinal fistula (HP:0100819) | 2.53227470 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.53178490 |
| 81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.52711933 |
| 82 | Increased serum pyruvate (HP:0003542) | 2.48523810 |
| 83 | Abnormality of glycolysis (HP:0004366) | 2.48523810 |
| 84 | Myocardial infarction (HP:0001658) | 2.47380605 |
| 85 | Peritonitis (HP:0002586) | 2.46642168 |
| 86 | Purpura (HP:0000979) | 2.45392042 |
| 87 | Recurrent skin infections (HP:0001581) | 2.42639160 |
| 88 | Chronic diarrhea (HP:0002028) | 2.41467889 |
| 89 | Gingival bleeding (HP:0000225) | 2.41150538 |
| 90 | Stomatitis (HP:0010280) | 2.39765446 |
| 91 | Abnormality of the pulmonary veins (HP:0011718) | 2.39210851 |
| 92 | Preauricular skin tag (HP:0000384) | 2.38881754 |
| 93 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38692663 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 2.38176303 |
| 95 | Eosinophilia (HP:0001880) | 2.34809985 |
| 96 | Spinal muscular atrophy (HP:0007269) | 2.33550075 |
| 97 | Meckel diverticulum (HP:0002245) | 2.32517159 |
| 98 | Partial duplication of the phalanx of hand (HP:0009999) | 2.32348099 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.32044770 |
| 100 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.31670541 |
| 101 | Abnormality of T cell physiology (HP:0011840) | 2.29248505 |
| 102 | Skin nodule (HP:0200036) | 2.28322024 |
| 103 | Testicular atrophy (HP:0000029) | 2.27374679 |
| 104 | Hypochromic anemia (HP:0001931) | 2.26563264 |
| 105 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.25018163 |
| 106 | Leukocytosis (HP:0001974) | 2.24678957 |
| 107 | Autoimmune hemolytic anemia (HP:0001890) | 2.23546962 |
| 108 | Meningitis (HP:0001287) | 2.22967166 |
| 109 | Granulocytopenia (HP:0001913) | 2.21438052 |
| 110 | Amyotrophic lateral sclerosis (HP:0007354) | 2.21326900 |
| 111 | Upper motor neuron abnormality (HP:0002127) | 2.20575058 |
| 112 | Angiofibromas (HP:0010615) | 2.19854697 |
| 113 | Adenoma sebaceum (HP:0009720) | 2.19854697 |
| 114 | Hand muscle atrophy (HP:0009130) | 2.19459541 |
| 115 | Shawl scrotum (HP:0000049) | 2.18065285 |
| 116 | Generalized hypotonia (HP:0001290) | 2.17844020 |
| 117 | Orchitis (HP:0100796) | 2.17788072 |
| 118 | Cheilitis (HP:0100825) | 2.15381673 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15338094 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15338094 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15338094 |
| 122 | Abnormality of B cell number (HP:0010975) | 2.14908831 |
| 123 | Glossoptosis (HP:0000162) | 2.14723155 |
| 124 | Abnormality of the ileum (HP:0001549) | 2.13389892 |
| 125 | IgA deficiency (HP:0002720) | 2.12176944 |
| 126 | Periauricular skin pits (HP:0100277) | 2.11561930 |
| 127 | Preauricular pit (HP:0004467) | 2.11561930 |
| 128 | Pustule (HP:0200039) | 2.10934517 |
| 129 | Horizontal nystagmus (HP:0000666) | 2.10621279 |
| 130 | Tetraparesis (HP:0002273) | 2.09603594 |
| 131 | Microvesicular hepatic steatosis (HP:0001414) | 2.08989913 |
| 132 | Disinhibition (HP:0000734) | 2.08403356 |
| 133 | Amaurosis fugax (HP:0100576) | 2.07688911 |
| 134 | Mucosal telangiectasiae (HP:0100579) | 2.06849471 |
| 135 | Abnormality of the motor neurons (HP:0002450) | 2.06215485 |
| 136 | Abnormal neuron morphology (HP:0012757) | 2.06215485 |
| 137 | Viral hepatitis (HP:0006562) | 2.05985488 |
| 138 | Increased serum ferritin (HP:0003281) | 2.04848028 |
| 139 | Nasolacrimal duct obstruction (HP:0000579) | 2.02642407 |
| 140 | Short 5th finger (HP:0009237) | 2.02050798 |
| 141 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.01908360 |
| 142 | Villous atrophy (HP:0011473) | 2.01908360 |
| 143 | Fasciculations (HP:0002380) | 2.01453192 |
| 144 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01310962 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 2.00099986 |
| 146 | Osteomyelitis (HP:0002754) | 1.99999981 |
| 147 | IgG deficiency (HP:0004315) | 1.97366941 |
| 148 | Hemoptysis (HP:0002105) | 1.97250031 |
| 149 | Skin tags (HP:0010609) | 1.97174940 |
| 150 | Gastrointestinal infarctions (HP:0005244) | 1.96992764 |
| 151 | Facial diplegia (HP:0001349) | 1.95792581 |
| 152 | Vasculitis (HP:0002633) | 1.95726458 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95345601 |
| 154 | Mucopolysacchariduria (HP:0008155) | 1.95345601 |
| 155 | Menorrhagia (HP:0000132) | 1.94500928 |
| 156 | Poor head control (HP:0002421) | 1.93338755 |
| 157 | Neoplasm of the heart (HP:0100544) | 1.93000652 |
| 158 | Increased connective tissue (HP:0009025) | 1.92093814 |
| 159 | Spondylolisthesis (HP:0003302) | 1.91538666 |
| 160 | Facial cleft (HP:0002006) | 1.89927985 |
| 161 | Agammaglobulinemia (HP:0004432) | 1.89866253 |
| 162 | Abnormality of chromosome segregation (HP:0002916) | 1.87398286 |
| 163 | Systemic lupus erythematosus (HP:0002725) | 1.86817814 |
| 164 | Glioma (HP:0009733) | 1.86105641 |
| 165 | Small intestinal stenosis (HP:0012848) | 1.85969669 |
| 166 | Duodenal stenosis (HP:0100867) | 1.85969669 |
| 167 | Chest pain (HP:0100749) | 1.85830572 |
| 168 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83869061 |
| 169 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83869061 |
| 170 | Abnormal protein glycosylation (HP:0012346) | 1.83869061 |
| 171 | Abnormal glycosylation (HP:0012345) | 1.83869061 |
| 172 | Aplastic anemia (HP:0001915) | 1.83767029 |
| 173 | Microretrognathia (HP:0000308) | 1.83517902 |
| 174 | Myositis (HP:0100614) | 1.83367547 |
| 175 | Webbed neck (HP:0000465) | 1.83135058 |
| 176 | Nemaline bodies (HP:0003798) | 1.82410621 |
| 177 | IgM deficiency (HP:0002850) | 1.81981774 |
| 178 | Inflammation of the large intestine (HP:0002037) | 1.81159196 |
| 179 | Abnormality of eosinophils (HP:0001879) | 1.81051566 |
| 180 | Mutism (HP:0002300) | 1.80357818 |
| 181 | Cortical dysplasia (HP:0002539) | 1.79674766 |
| 182 | Cholecystitis (HP:0001082) | 1.77907293 |
| 183 | Abnormal gallbladder physiology (HP:0012438) | 1.77907293 |
| 184 | Lymphopenia (HP:0001888) | 1.77777360 |
| 185 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77152735 |
| 186 | B lymphocytopenia (HP:0010976) | 1.76925547 |
| 187 | Hyperlipoproteinemia (HP:0010980) | 1.76739641 |
| 188 | Polyneuropathy (HP:0001271) | 1.74659906 |
| 189 | Urticaria (HP:0001025) | 1.74054257 |
| 190 | Hydroxyprolinuria (HP:0003080) | 1.73573283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.96440050 |
| 2 | ERN1 | 5.83708284 |
| 3 | GRK5 | 4.43977302 |
| 4 | GRK6 | 3.85562191 |
| 5 | ACVR1B | 3.73630376 |
| 6 | CSF1R | 3.21208932 |
| 7 | TGFBR2 | 3.02872411 |
| 8 | ADRBK2 | 2.83073254 |
| 9 | TRIM28 | 2.66709385 |
| 10 | GRK1 | 2.64331966 |
| 11 | STK10 | 2.58548737 |
| 12 | GRK7 | 2.48770785 |
| 13 | RIPK4 | 2.44755042 |
| 14 | MATK | 2.42412100 |
| 15 | MAP3K14 | 2.27083412 |
| 16 | PRPF4B | 2.22866824 |
| 17 | MOS | 2.19572041 |
| 18 | NEK9 | 2.13120438 |
| 19 | FGR | 2.05291872 |
| 20 | MAP4K1 | 2.01514018 |
| 21 | TYRO3 | 2.00782047 |
| 22 | MAPK7 | 1.99634320 |
| 23 | TEC | 1.97543144 |
| 24 | MAP2K3 | 1.86636351 |
| 25 | FRK | 1.70055932 |
| 26 | TTK | 1.68182681 |
| 27 | MAP3K13 | 1.65021767 |
| 28 | TNIK | 1.64923443 |
| 29 | PIK3CG | 1.63239040 |
| 30 | EIF2AK3 | 1.60469789 |
| 31 | PAK4 | 1.59637395 |
| 32 | PRKG2 | 1.57006244 |
| 33 | MST4 | 1.46108566 |
| 34 | MYLK | 1.45963235 |
| 35 | CDK7 | 1.43537244 |
| 36 | BTK | 1.41482197 |
| 37 | EPHB1 | 1.38344328 |
| 38 | BMPR2 | 1.38316546 |
| 39 | FGFR3 | 1.37411717 |
| 40 | MARK3 | 1.33472561 |
| 41 | BUB1 | 1.32991368 |
| 42 | MAP4K2 | 1.27431973 |
| 43 | EPHA2 | 1.24993447 |
| 44 | IRAK3 | 1.23791962 |
| 45 | ERBB3 | 1.21027872 |
| 46 | WNK1 | 1.20788945 |
| 47 | HIPK2 | 1.19595087 |
| 48 | MAP3K3 | 1.17276370 |
| 49 | MAP3K5 | 1.12379772 |
| 50 | BLK | 1.11459540 |
| 51 | NUAK1 | 1.09012071 |
| 52 | PIM2 | 1.08844557 |
| 53 | IKBKE | 1.08439704 |
| 54 | PTK2B | 1.06928781 |
| 55 | TAOK3 | 1.06351524 |
| 56 | ADRBK1 | 1.04848563 |
| 57 | FES | 0.98856754 |
| 58 | CAMK4 | 0.98321032 |
| 59 | CHEK2 | 0.95740103 |
| 60 | MELK | 0.95050148 |
| 61 | PLK1 | 0.91673499 |
| 62 | CSK | 0.91344714 |
| 63 | JAK2 | 0.90240249 |
| 64 | ITK | 0.89544861 |
| 65 | BMPR1B | 0.89043044 |
| 66 | NTRK1 | 0.85559294 |
| 67 | KIT | 0.82333665 |
| 68 | BMX | 0.81705186 |
| 69 | MAPKAPK3 | 0.79603344 |
| 70 | IRAK1 | 0.77887376 |
| 71 | TYK2 | 0.77455983 |
| 72 | TRPM7 | 0.76645736 |
| 73 | EIF2AK1 | 0.75832686 |
| 74 | TESK2 | 0.73808408 |
| 75 | FLT3 | 0.73505232 |
| 76 | DYRK2 | 0.73460867 |
| 77 | ZAK | 0.73213706 |
| 78 | TIE1 | 0.72516711 |
| 79 | BRSK2 | 0.72104533 |
| 80 | IKBKB | 0.69091085 |
| 81 | EIF2AK2 | 0.66468285 |
| 82 | STK3 | 0.65442778 |
| 83 | BCKDK | 0.65044165 |
| 84 | NME2 | 0.64837068 |
| 85 | MARK2 | 0.64185635 |
| 86 | PASK | 0.62702252 |
| 87 | PRKCD | 0.61733649 |
| 88 | PRKCQ | 0.61596374 |
| 89 | CDK6 | 0.61408229 |
| 90 | MAP2K6 | 0.60863766 |
| 91 | CHUK | 0.60805564 |
| 92 | MAP3K10 | 0.60759482 |
| 93 | TRIB3 | 0.60335641 |
| 94 | FGFR4 | 0.58131863 |
| 95 | AKT3 | 0.58121562 |
| 96 | IGF1R | 0.56872430 |
| 97 | ABL1 | 0.56590761 |
| 98 | LRRK2 | 0.54903208 |
| 99 | NEK1 | 0.54240486 |
| 100 | PRKCI | 0.53542773 |
| 101 | AKT2 | 0.53320081 |
| 102 | PTK2 | 0.53114543 |
| 103 | YES1 | 0.52829798 |
| 104 | PAK3 | 0.52798157 |
| 105 | TESK1 | 0.52443477 |
| 106 | MAPKAPK2 | 0.52167471 |
| 107 | INSRR | 0.51437188 |
| 108 | CAMKK2 | 0.50723614 |
| 109 | EGFR | 0.49450173 |
| 110 | AURKA | 0.49220033 |
| 111 | FER | 0.48746353 |
| 112 | SRPK1 | 0.48115414 |
| 113 | MAPK11 | 0.47668323 |
| 114 | SCYL2 | 0.47367190 |
| 115 | OBSCN | 0.47353754 |
| 116 | KSR1 | 0.46484566 |
| 117 | PRKD2 | 0.45162266 |
| 118 | NEK2 | 0.45107182 |
| 119 | CHEK1 | 0.44813818 |
| 120 | IRAK4 | 0.44716942 |
| 121 | PKN2 | 0.42848701 |
| 122 | TTN | 0.42731645 |
| 123 | PAK1 | 0.42446205 |
| 124 | SIK3 | 0.41507982 |
| 125 | PBK | 0.41274307 |
| 126 | PIM1 | 0.41014477 |
| 127 | CDC42BPA | 0.40955790 |
| 128 | EPHA3 | 0.40052546 |
| 129 | JAK3 | 0.39954747 |
| 130 | STK4 | 0.38884587 |
| 131 | NLK | 0.38542984 |
| 132 | TAOK1 | 0.38088494 |
| 133 | ZAP70 | 0.36782043 |
| 134 | KSR2 | 0.36779504 |
| 135 | TBK1 | 0.32203741 |
| 136 | BCR | 0.32118288 |
| 137 | RPS6KB2 | 0.31875564 |
| 138 | CDK8 | 0.31840760 |
| 139 | TGFBR1 | 0.31526290 |
| 140 | HCK | 0.30764638 |
| 141 | MTOR | 0.30480280 |
| 142 | VRK1 | 0.29939918 |
| 143 | DDR2 | 0.29878050 |
| 144 | PDGFRA | 0.29740935 |
| 145 | JAK1 | 0.29657703 |
| 146 | INSR | 0.27696992 |
| 147 | LCK | 0.26723748 |
| 148 | CDK2 | 0.25409078 |
| 149 | ALK | 0.25266171 |
| 150 | DYRK1B | 0.24000724 |
| 151 | ERBB2 | 0.23394108 |
| 152 | DYRK3 | 0.22798060 |
| 153 | AURKB | 0.21608140 |
| 154 | ARAF | 0.21333592 |
| 155 | MAPK12 | 0.20587676 |
| 156 | KDR | 0.19676295 |
| 157 | LATS2 | 0.18844231 |
| 158 | SYK | 0.18827412 |
| 159 | TAOK2 | 0.16155464 |
| 160 | TXK | 0.15443280 |
| 161 | PTK6 | 0.15377151 |
| 162 | MAP2K4 | 0.15373944 |
| 163 | LYN | 0.15117052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.47572530 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.05855980 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.82852278 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 3.47784418 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.83469032 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.59001663 |
| 7 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.41991588 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.29860422 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28534450 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.19445341 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15352100 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06002764 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00874639 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91517341 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.85727382 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79868345 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.73375742 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.67720435 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62261719 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.55689200 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55322413 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.55044802 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.53440485 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.53265276 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52823433 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.52376469 |
| 27 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.51481662 |
| 28 | Proteasome_Homo sapiens_hsa03050 | 1.49459330 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48975454 |
| 30 | DNA replication_Homo sapiens_hsa03030 | 1.46208880 |
| 31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.45422924 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.40454492 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34636014 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34363578 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.31520976 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25033012 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.24994096 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.23840913 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23765171 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22553917 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21815454 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20420100 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.16875616 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14619904 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13705289 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12633273 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11233735 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07933598 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06103380 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.05844450 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 1.02041445 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01911477 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.99488557 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.98030433 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97000476 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96446798 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 0.95680947 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95377066 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94232225 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85097070 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79772122 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78582429 |
| 63 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.78461535 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78105347 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76425272 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76334157 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76221639 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.75303763 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74910471 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74656243 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73448927 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73326893 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72456345 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70489721 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70341379 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.70322324 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69526523 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.69447015 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69305832 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69177829 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68796406 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68183829 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65802126 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63935871 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62637941 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62412893 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.62185357 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62051284 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58755008 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58615558 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.58402677 |
| 92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57499844 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57378737 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.56491608 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56420314 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55867227 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55337883 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53847485 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52382279 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51225750 |
| 101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50587889 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.50131148 |
| 103 | RNA polymerase_Homo sapiens_hsa03020 | 0.49359367 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48663687 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48341865 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.47859127 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.47398724 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47053033 |
| 109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46626827 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46559953 |
| 111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44431703 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44242870 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43451011 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42965914 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.42859167 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42159025 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42041661 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.41632096 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41165116 |
| 120 | Tuberculosis_Homo sapiens_hsa05152 | 0.41013863 |
| 121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40324995 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40167816 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40119708 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39468036 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.39333681 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38699945 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38699675 |
| 128 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38460037 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37897914 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36869036 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36470474 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36446701 |
| 133 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35724905 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35660072 |
| 135 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.35511635 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35450424 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35207167 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34910273 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.34862178 |
| 140 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.34410930 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34363886 |
| 142 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33949492 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33453712 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32844069 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32464455 |
| 146 | Malaria_Homo sapiens_hsa05144 | 0.31295972 |
| 147 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31220181 |
| 148 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30810566 |
| 149 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29913599 |
| 150 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29403586 |

